Technical Analysis for ICOTF - Ico Therapeutics

Grade Last Price % Change Price Change
grade C 0.0359 -11.58% -0.0047
ICOTF closed down 11.58 percent on Thursday, August 6, 2020, on 4 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical ICOTF trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Pocket Pivot Bullish Swing Setup -11.58%
Outside Day Range Expansion -11.58%
Wide Bands Range Expansion -11.58%
Narrow Range Bar Range Contraction -0.83%
Wide Bands Range Expansion -0.83%
Gapped Down Weakness -0.83%
Older signals for ICOTF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.
Health Biotechnology Branches Of Biology Clinical Trial Allergic Conjunctivitis Cytokines

Is ICOTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.114
52 Week Low 0.0155
Average Volume 51,976
200-Day Moving Average 0.0489
50-Day Moving Average 0.0315
20-Day Moving Average 0.0324
10-Day Moving Average 0.0348
Average True Range 0.0054
ADX 10.95
+DI 41.8637
-DI 30.5981
Chandelier Exit (Long, 3 ATRs ) 0.0318
Chandelier Exit (Short, 3 ATRs ) 0.0401
Upper Bollinger Band 0.0424
Lower Bollinger Band 0.0224
Percent B (%b) 0.68
BandWidth 61.7284
MACD Line 0.0020
MACD Signal Line 0.0010
MACD Histogram 0.001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0359
Resistance 3 (R3) 0.0359 0.0359 0.0359
Resistance 2 (R2) 0.0359 0.0359 0.0359 0.0359
Resistance 1 (R1) 0.0359 0.0359 0.0359 0.0359 0.0359
Pivot Point 0.0359 0.0359 0.0359 0.0359 0.0359
Support 1 (S1) 0.0359 0.0359 0.0359 0.0359 0.0359
Support 2 (S2) 0.0359 0.0359 0.0359 0.0359
Support 3 (S3) 0.0359 0.0359 0.0359
Support 4 (S4) 0.0359